No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Angiogenesis Inhibitors / pharmacology*
-
Angiogenesis Inhibitors / therapeutic use
-
Animals
-
Antineoplastic Agents / pharmacology*
-
Antineoplastic Agents / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / pharmacology
-
Clinical Trials as Topic
-
Endothelial Growth Factors / antagonists & inhibitors
-
Humans
-
Lymphokines / antagonists & inhibitors
-
Metalloendopeptidases / antagonists & inhibitors
-
Neoplasms / blood supply
-
Neoplasms / drug therapy*
-
Neovascularization, Pathologic / drug therapy*
-
Neovascularization, Pathologic / prevention & control*
-
Receptor Protein-Tyrosine Kinases / antagonists & inhibitors
-
Receptors, Growth Factor / antagonists & inhibitors
-
Receptors, Vascular Endothelial Growth Factor
-
Treatment Outcome
-
Vascular Endothelial Growth Factor A
-
Vascular Endothelial Growth Factors
Substances
-
Angiogenesis Inhibitors
-
Antineoplastic Agents
-
Endothelial Growth Factors
-
Lymphokines
-
Receptors, Growth Factor
-
Vascular Endothelial Growth Factor A
-
Vascular Endothelial Growth Factors
-
Receptor Protein-Tyrosine Kinases
-
Receptors, Vascular Endothelial Growth Factor
-
Metalloendopeptidases